Skip to main content
. Author manuscript; available in PMC: 2022 Apr 15.
Published in final edited form as: Int J Cardiol. 2020 Dec 24;329:123–129. doi: 10.1016/j.ijcard.2020.12.048

Figure 1.

Figure 1.

Rate of guideline-directed medical therapy over time in HF QUIK. Figure Legend: Interrupted time series model graphs for the primary outcome of guideline-directed medical therapy (A); its components: ACE-I or ARB (B), beta-blocker (C) and aldosterone antagonist (D) are shown. The white background indicates control period and grey background indicates intervention period.

ACE-I: angiotensin converting enzyme inhibitor, ARB: angiotensin receptor blocker.